Navigation Links
Amgen to Review Results From TREAT and Propose Updates to ESA Labeling for Chronic Renal Failure Patients at an FDA Advisory Committee Meeting Today
Date:10/18/2010

Aranesp to a target hemoglobin of 13 g/dL or placebo. Due to the increased risk of negative outcomes associated with low hemoglobin levels, patients in the control arm whose hemoglobin fell below 9 g/dL were given Aranesp as a rescue medication until their hemoglobin level reached 9 g/dL. Investigators were blinded to this intervention.

The key findings from TREAT include:

  • The study failed to meet either of its primary endpoints of:
  • improving mortality and CV morbidity or
  • extending time to death or ESRD

  • TREAT showed:
  • An almost 2-fold increased risk of stroke (HR = 1.92 [95 percent CI: 1.38-2.68], annualized incidence rate 2.1 percent vs. 1.1 percent) in the Aranesp arm
  • Among patients with history of malignancy, a higher number of deaths due to any cause and of death adjudicated as due to malignancy in the Aranesp arm
  • Aranesp therapy significantly reduced the need for transfusions
  • A statistically-significant but clinically modest improvement in patient-reported outcomes for patients in the Aranesp arm

  • Chronic Kidney Disease: Impact and PrevalenceCKD affects more than 26 million Americans and millions more worldwide. The disease is characterized by progressive kidney damage and impaired kidney function and is most often caused by type-2 diabetes or high blood pressure. When CKD progresses to kidney failure, chronic dialysis or a kidney transplant are required to sustain life. Anemia is a common complication of CKD that may begin in the early stages of the disease and becomes more common and severe as kidney function declines.

    About AranespAranesp was approved by the FDA in 2001 for the treatment of anemia associated with CRF for patients on dialysis and patients not on dialysis. The European Commission granted marketing authorization for the same indication in 2001 and subsequently updated it for CRF patients with symptomatic anemia in 2008.

    In 2002, the
    '/>"/>

    SOURCE Amgen
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
    2. Medarex to Receive Milestone Payment from Amgen
    3. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
    4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
    5. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
    6. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
    7. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
    8. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
    9. Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP
    10. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
    11. Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... , Dec. 24, 2014  Novastem, a leader ... first patient in its study for ischemic stroke ... Stroke Association, ischemic strokes account for 87 percent ... qualified patients in the study, entitled "Internal Research ... Allogeneic Mesenchymal Stem Cells and Intrathecal Administration of ...
    (Date:12/24/2014)... PRINCETON, N.J. , Dec. 24, 2014 /PRNewswire/ ... Company), a late-stage biopharmaceutical company developing products that ... inflammation, oncology and biodefense, announced today that on ... registered public offering. The Company raised ... offering and intends to use the net proceeds ...
    (Date:12/24/2014)... YORK and LONDON , ... global orthopedic industry are expected to grow at an ... in terms of value and volume. Hip, knee and ... developed world while in emerging economies they have a ... rates are challenging the use of composites. Non-metallic orthopedic ...
    Breaking Medicine Technology:Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3
    ... April 4, 2012  Syndicus, Inc. and Fayetteville, ... forged a strategic alliance that will ultimately ... paper-based records to federally mandated electronic health ... companies will work closely to promote and ...
    ... 4, 2012   CoreBrand , a leading brand strategy ... Branding Index® , which provides continuous benchmarking data, insights ... 54 industries, has recently been engaged by leading U.S. ... consumer industries for its expertise in crisis brand management. ...
    Cached Medicine Technology:Syndicus, Inc. Scientific Services, SOAPware Announce Strategic Alliance 2Fortune 100 Companies Turning to CoreBrand for Its Expertise in Crisis Brand Management 2Fortune 100 Companies Turning to CoreBrand for Its Expertise in Crisis Brand Management 3
    (Date:12/26/2014)... 2014 Cooking and warming equipment ... of 5. This score reflects slightly positive negotiation conditions ... specialization, low switching costs and a low level of ... low availability of substitutes for cooking and warming equipment ... and aluminum, key inputs in the production process of ...
    (Date:12/26/2014)... 26, 2014 India Network Foundation, a ... the USA, announced today a new version of “ ... choosing the right plan for their visiting parents. The ... of the selection process when choosing an insurance plan ... with only a few clicks. Many elderly Asian Indian ...
    (Date:12/25/2014)... This is a professional and in-depth study on ... a focus on the Chinese market. The report provides ... manufacturers and is a valuable source of guidance and ... This report provides a basic overview of the industry ... part, the report presents the company profile, product specifications, ...
    (Date:12/25/2014)... months the trends for evening dresses shift and ... of the hottest styles in the next few months.” The ... 26 A-line sweetheart evening dresses, and announces the availability of ... trying our best to help a lady to show off ... prices, we provide discounted delivery costs to our customers worldwide. ...
    (Date:12/25/2014)... BambooFlooringChina.com sells many bamboo products and the ... the company announces big discounts on its bamboo ... , BambooFlooringChina.com is the world’s leader in bamboo flooring. ... until Jan. 20, 2015. , The bamboo mats are ... natural thread. All the bamboo strips for the mats ...
    Breaking Medicine News(10 mins):Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 2Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 3Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
    ... (June 17, 2010)The Alliance for Academic Internal Medicine (AAIM) has ... education (GME) funding. In light of the current ... Commission,s (MedPAC,s) June 2010 report, AAIM encourages GME reform to ... The AAIM Principles for GME Reform ...
    ... ... medication expenses , ... Westerville, Ohio (PRWEB) June 17, 2010 -- Progressive Medical, Inc. ( http://www.progressive-medical.com ) announced ... medication spending on workers’ compensation claims from 2008 to 2009 for Progressive Medical clients, ...
    ... Normal weight and underweight teenage girls who falsely believe ... succumbing to unnecessary and unsafe weight-loss behaviors than girls ... new research by a University of Illinois expert in ... a professor of social work and of medicine at ...
    ... ... cost-effective cell culture media supplement that is consistent and animal component free. , ... Fort Collins, CO (PRWEB) ... steer cell culture scientists to re-evaluate their use of native transferrin and iron chelators ...
    ... validated by others brings mental satisfaction, study finds , THURSDAY, ... often leads to a sense of satisfaction, and a new ... area of the brain is activated when people agree with ... used functional MRI scans to monitor activity in the ventral ...
    ... ... and a lot of potential solutions to water scarcity have steep energy costs. , ... (PRWEB) June 17, 2010 -- This ... energy is critical to treating and moving water. According to a new special report in ...
    Cached Medicine News:Health News:Progressive Medical Releases 2010 Workers' Compensation Drug Spend Analysis 2Health News:Body-image distortion predicts onset of unsafe weight-loss behaviors 2Health News:Body-image distortion predicts onset of unsafe weight-loss behaviors 3Health News:Body-image distortion predicts onset of unsafe weight-loss behaviors 4Health News:Body-image distortion predicts onset of unsafe weight-loss behaviors 5Health News:Study Demonstrates a Safe and Cost Effective Source of Recombinant Human Transferrin 2Health News:Study Demonstrates a Safe and Cost Effective Source of Recombinant Human Transferrin 3Health News:Shared Opinions Light Up Brain's 'Reward Center' 2Health News:Green Energy May Drain Our Water Supplies 2Health News:Green Energy May Drain Our Water Supplies 3
    ... Blue Line® uncuffed endotracheal tubes ... Murphy styles, in standard or ... adult and pediatric uncuffed endotracheal ... polyvinyl chloride with a radiopaque ...
    Portex® Blue Line® cuffed endotracheal tubes come in a wide selection of sizes, each with a standard 15 mm ISO connector., ,Portex® Blue Line® endotracheal tubes are recognized world...
    ... PVC. 2 eyes, oral. Marked with ... X-ray opaque line. Graduated. Single use. ... reduce kinking of the tube by ... adapts to the anatomical situation at ...
    ... Tube with stylet inside. Sterile, Latex ... Rusch endotracheal tube with a preloaded ... saving you time and storage space. ... easy identification and has a stopper ...
    Medicine Products: